The Biosimilars Europe Congress 2017 is dedicated to current vital issues, regulatory issues, market assessment and commercialization and globalization of Biosimilars.
The Biosimilars Europe Congress 2017 covers topics such as:
- Monoclonal antibody Biosimilars.
- Current status of Biosimliars market.
- Opportunities in emerging markets.
- Challenges faced when moving towards globalization
- Partnership, new investment and business models.
- IP issues, naming and labeling issues related to biosimilars.
- Clinical trials strategies and new guidelines for biosimilar clinical trials.
- Challenges and opportunities for biobetters and monoclonal antibody biosimilars.
- Bringing biosimilars closer to patients and healthcare professionals.
- Benefits and concerns of interchangeable and biosubstitutes and post authorization monitoring.
- New solutions to demonstrate similarity and different characterization methods.
